200 related articles for article (PubMed ID: 28376720)
1. Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery.
Wysocka A; Cybulski M; Berbeć H; Wysokiński A; Stążka J; Daniluk J; Zapolski T
BMC Cardiovasc Disord; 2017 Apr; 17(1):92. PubMed ID: 28376720
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery.
Wysocka A; Cybulski M; Berbeć H; Wysokiński A; Stążka J; Zapolski T
Med Sci Monit; 2014 Apr; 20():594-600. PubMed ID: 24721823
[TBL] [Abstract][Full Text] [Related]
3. [Decrease of paraoxonase activity in the first day after abdominal operations in women].
Szymczyk G; Bełtowski J; Maciejczyk-Pencuła M; Kotarski J
Ginekol Pol; 2004 Jul; 75(7):528-32. PubMed ID: 15517772
[TBL] [Abstract][Full Text] [Related]
4. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
5. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
6. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery.
Wysocka A; Cybulski M; P Wysokiński A; Berbeć H; Stążka J; Zapolski T
J Clin Med; 2019 Mar; 8(4):. PubMed ID: 30935088
[TBL] [Abstract][Full Text] [Related]
8. The effect of divalent metal chelators and cadmium on serum phosphotriesterase, lactonase and arylesterase activities of paraoxonase 1.
Bizoń A; Milnerowicz H
Environ Toxicol Pharmacol; 2018 Mar; 58():77-83. PubMed ID: 29306821
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase-1 (PON1) activity, but not PON1(Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population.
Kotur-Stevuljevic J; Spasic S; Stefanovic A; Zeljkovic A; Bogavac-Stanojevic N; Kalimanovska-Ostric D; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z
Clin Chem Lab Med; 2006; 44(10):1206-13. PubMed ID: 17032132
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase 1 activity in different types of multiple sclerosis.
Jamroz-Wisniewska A; Beltowski J; Stelmasiak Z; Bartosik-Psujek H
Mult Scler; 2009 Mar; 15(3):399-402. PubMed ID: 18845659
[TBL] [Abstract][Full Text] [Related]
11. Effect of dilution on high-density lipoprotein associated paraoxonase-1 activity.
Mackness M; Mackness B
Clin Biochem; 2011 Oct; 44(14-15):1270-1. PubMed ID: 21854764
[TBL] [Abstract][Full Text] [Related]
12. Effect of preoperative atorvastatin therapy on paraoxonase activity and oxidative stress after coronary artery bypass grafting.
Kurban S; Mehmetoglu I; Ege E
Perfusion; 2009 Jul; 24(4):271-6. PubMed ID: 19843623
[TBL] [Abstract][Full Text] [Related]
13. Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration.
Bełtowski J; Wójcicka G; Marciniak A
Acta Biochim Pol; 2002; 49(4):927-36. PubMed ID: 12545199
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
Rumora L; Rajković MG; Kopčinović LM; Pancirov D; Čepelak I; Grubišić TŽ
COPD; 2014 Sep; 11(5):539-45. PubMed ID: 24831724
[TBL] [Abstract][Full Text] [Related]
16. Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate.
Charlton-Menys V; Liu Y; Durrington PN
Clin Chem; 2006 Mar; 52(3):453-7. PubMed ID: 16423902
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
Mackness B; Davies GK; Turkie W; Lee E; Roberts DH; Hill E; Roberts C; Durrington PN; Mackness MI
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1451-7. PubMed ID: 11557671
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase activity in Greek migrants and Anglo-Celtic persons in the Melbourne Collaborative Cohort Study: relationship to dietary markers.
Lee CT; Rowley K; Jenkins AJ; O'Dea K; Itsiopoulos C; Stoney RM; Su Q; Giles GG; Best JD
Eur J Nutr; 2005 Jun; 44(4):223-30. PubMed ID: 15309416
[TBL] [Abstract][Full Text] [Related]
19. Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.
Mahrooz A; Shokri Y; Variji A; Zargari M; Alizadeh A; Mehtarian E
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1166-1176. PubMed ID: 33579580
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 low activity and SYNTAX score may predict postoperative complications after coronary artery surgery.
Vukicevic P; Klisic A; Kotur-Stevuljevic J; Mikic A; Bogavac-Stanojevic N; Matkovic M; Putnik S; Aleksic N; Tutus V; Karikas GA
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1511-1521. PubMed ID: 33629320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
